Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.5599 USD | -4.16% | -14.48% | -60.01% |
Apr. 09 | Seres Therapeutics Announces Completion of Patient Enrollment for SER-155 Phase 1B Cohort 2 Clinical Trial in Allogenic HSCT | CI |
Apr. 08 | Declaration of Voting Results by Seres Therapeutics | CI |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-60.01% | 88.22M | |
-3.10% | 102B | |
+2.11% | 96.07B | |
-1.80% | 21.66B | |
-17.75% | 20.77B | |
-6.91% | 18.53B | |
-42.00% | 16.91B | |
-28.19% | 13.79B | |
+0.18% | 13.33B | |
+19.90% | 10.94B |
- Stock Market
- Equities
- MCRB Stock
- News Seres Therapeutics, Inc.
- Seres Therapeutics Swings to Profit in Q3 as Revenue Surges, Partners With Bacthera to Produce Treatment Against Microbial Infection